Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Viralkumar Shah

Concepts (307)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetes Mellitus, Type 1
112
2026
3788
16.470
 Why?
Hypoglycemic Agents
64
2026
1368
11.630
 Why?
Blood Glucose
78
2026
2273
9.090
 Why?
Blood Glucose Self-Monitoring
61
2026
704
7.980
 Why?
Insulin Infusion Systems
36
2026
466
6.690
 Why?
Insulin
49
2026
2458
6.550
 Why?
Hypoglycemia
27
2026
467
5.990
 Why?
Diabetes Mellitus, Type 2
21
2025
2524
3.910
 Why?
Pancreas, Artificial
9
2025
99
3.150
 Why?
Biosimilar Pharmaceuticals
5
2024
27
2.950
 Why?
Insulin Glargine
7
2025
84
2.940
 Why?
Diabetes Mellitus
11
2025
1072
2.710
 Why?
Diabetic Retinopathy
5
2026
201
2.570
 Why?
Osteoporotic Fractures
6
2020
61
2.530
 Why?
Insulin Aspart
5
2024
30
2.490
 Why?
Bone Density
11
2025
495
2.330
 Why?
Fractures, Bone
8
2024
406
2.320
 Why?
Adult
91
2026
39134
2.080
 Why?
Diabetic Ketoacidosis
4
2022
209
1.980
 Why?
Hyperglycemia
8
2024
363
1.950
 Why?
Humans
149
2026
140898
1.750
 Why?
Middle Aged
62
2026
34487
1.470
 Why?
Hyperparathyroidism, Primary
5
2014
7
1.460
 Why?
Young Adult
47
2026
13646
1.380
 Why?
Female
81
2026
75540
1.300
 Why?
Male
77
2026
69893
1.300
 Why?
Diabetes Complications
4
2020
222
1.240
 Why?
Peptides
2
2025
979
1.200
 Why?
Femur Neck
4
2022
63
1.190
 Why?
Obesity
5
2025
3000
1.180
 Why?
Adolescent
39
2026
22027
0.970
 Why?
Pregnancy in Diabetics
2
2025
124
0.910
 Why?
Marijuana Abuse
2
2019
230
0.900
 Why?
Liraglutide
1
2024
31
0.890
 Why?
Cannabis
3
2022
510
0.880
 Why?
Glucose
6
2023
1031
0.880
 Why?
Treatment Outcome
17
2026
11125
0.850
 Why?
Glucagon-Like Peptides
1
2025
60
0.850
 Why?
Risk Factors
18
2024
10430
0.840
 Why?
Insulin, Long-Acting
3
2021
64
0.810
 Why?
Bone and Bones
2
2023
313
0.780
 Why?
Sweetening Agents
1
2023
55
0.780
 Why?
Bone Remodeling
2
2020
76
0.770
 Why?
Gastroparesis
2
2019
9
0.760
 Why?
Registries
10
2021
2143
0.750
 Why?
Vitamin D
3
2014
392
0.750
 Why?
Cardiovascular Diseases
6
2022
2082
0.750
 Why?
Consensus
1
2024
545
0.730
 Why?
Ketosis
1
2022
12
0.730
 Why?
RNAi Therapeutics
1
2021
6
0.730
 Why?
Hyperoxaluria, Primary
1
2021
14
0.720
 Why?
Insulins
1
2022
37
0.710
 Why?
Patient Satisfaction
2
2025
690
0.700
 Why?
Automobile Driving
1
2023
152
0.680
 Why?
Non-alcoholic Fatty Liver Disease
1
2024
263
0.670
 Why?
Osteoporosis
3
2020
242
0.660
 Why?
Incretins
1
2020
21
0.660
 Why?
Blindness
1
2020
49
0.640
 Why?
Aged
29
2026
24666
0.640
 Why?
Diabetes, Gestational
1
2024
318
0.640
 Why?
Bone Resorption
1
2020
84
0.630
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2025
48
0.620
 Why?
Feasibility Studies
1
2024
1022
0.620
 Why?
Hip Fractures
1
2020
86
0.610
 Why?
Self-Management
2
2020
199
0.610
 Why?
Age Factors
6
2020
3278
0.600
 Why?
Osteoporosis, Postmenopausal
1
2019
42
0.590
 Why?
Osteogenesis
1
2020
198
0.570
 Why?
Child
24
2026
22313
0.570
 Why?
Absorptiometry, Photon
5
2025
265
0.570
 Why?
Self Care
2
2018
392
0.560
 Why?
Parathyroid Hormone
4
2014
111
0.550
 Why?
Bone Diseases
1
2018
66
0.540
 Why?
Quality of Life
5
2026
3005
0.540
 Why?
Monitoring, Physiologic
1
2019
285
0.530
 Why?
Body Mass Index
6
2025
2374
0.510
 Why?
Drugs, Investigational
1
2017
31
0.510
 Why?
Calcium
6
2014
1190
0.500
 Why?
Fractures, Spontaneous
1
2015
16
0.480
 Why?
Marijuana Smoking
1
2019
262
0.480
 Why?
Accidental Falls
1
2018
213
0.470
 Why?
Retrospective Studies
15
2026
16315
0.460
 Why?
Glucagon-Like Peptide-2 Receptor
2
2025
17
0.460
 Why?
Vitamin D Deficiency
2
2014
187
0.450
 Why?
Weight Loss
3
2025
790
0.450
 Why?
Gallstones
1
2014
33
0.420
 Why?
Case-Control Studies
7
2026
3578
0.410
 Why?
Glucose Intolerance
1
2015
147
0.410
 Why?
Cross-Sectional Studies
9
2025
5645
0.410
 Why?
Insulin Lispro
2
2024
42
0.400
 Why?
Prospective Studies
10
2025
7749
0.390
 Why?
Longitudinal Studies
4
2025
2920
0.390
 Why?
Pancreatitis
1
2014
136
0.390
 Why?
Suicide
1
2020
669
0.380
 Why?
Clinical Trials as Topic
3
2026
1031
0.370
 Why?
Sex Factors
5
2025
2051
0.360
 Why?
Bone Diseases, Metabolic
3
2019
64
0.360
 Why?
United States
11
2025
15195
0.360
 Why?
Diabetic Angiopathies
3
2020
250
0.350
 Why?
Prediabetic State
2
2025
251
0.350
 Why?
Gastrointestinal Tract
1
2014
197
0.350
 Why?
Surveys and Questionnaires
5
2026
5931
0.350
 Why?
Bromocriptine
2
2025
31
0.340
 Why?
Meals
3
2024
132
0.330
 Why?
Autoimmune Diseases
1
2015
465
0.330
 Why?
Islet Amyloid Polypeptide
2
2025
48
0.320
 Why?
Sex Characteristics
3
2025
785
0.320
 Why?
Drug Therapy, Combination
2
2025
1038
0.320
 Why?
Pregnancy
6
2025
7035
0.310
 Why?
Glucagon-Like Peptide 1
2
2025
133
0.300
 Why?
History, 20th Century
4
2025
325
0.300
 Why?
Autoantibodies
2
2018
1474
0.280
 Why?
Randomized Controlled Trials as Topic
3
2025
1598
0.280
 Why?
Cross-Over Studies
5
2025
577
0.280
 Why?
Diabetic Nephropathies
2
2024
293
0.280
 Why?
Reference Values
2
2019
803
0.260
 Why?
Prevalence
5
2023
2780
0.260
 Why?
India
4
2015
208
0.260
 Why?
Phenotype
1
2015
3172
0.260
 Why?
Metformin
2
2025
329
0.250
 Why?
Risk Assessment
3
2020
3484
0.250
 Why?
Follow-Up Studies
4
2026
5194
0.240
 Why?
Solid Waste
1
2025
3
0.230
 Why?
Thyrotoxicosis
1
2024
8
0.220
 Why?
Manitoba
1
2024
4
0.220
 Why?
Smartphone
1
2025
89
0.220
 Why?
Phosphates
3
2014
179
0.210
 Why?
History, 21st Century
3
2025
218
0.210
 Why?
Proof of Concept Study
1
2024
85
0.210
 Why?
ROC Curve
1
2025
589
0.210
 Why?
Glucagon-Like Peptide-1 Receptor
1
2024
78
0.200
 Why?
Drug Substitution
1
2024
60
0.200
 Why?
Artificial Organs
1
2023
2
0.200
 Why?
Algorithms
3
2024
1763
0.200
 Why?
Germany
2
2020
131
0.200
 Why?
Glycemic Index
1
2022
26
0.190
 Why?
Cost-Benefit Analysis
1
2025
609
0.190
 Why?
Minority Groups
2
2023
277
0.180
 Why?
Autonomic Nervous System Diseases
1
2022
32
0.180
 Why?
Reproducibility of Results
5
2024
3336
0.180
 Why?
Gastric Emptying
1
2021
36
0.180
 Why?
Computer Systems
2
2018
51
0.180
 Why?
Aged, 80 and over
5
2021
7899
0.170
 Why?
Vision Screening
1
2021
46
0.170
 Why?
Exercise
2
2025
2108
0.170
 Why?
Calibration
2
2018
152
0.170
 Why?
Body Composition
1
2025
703
0.170
 Why?
Diabetic Neuropathies
1
2022
94
0.170
 Why?
Biomarkers
3
2023
4175
0.170
 Why?
Incidence
2
2026
2782
0.170
 Why?
Glucagon-Like Peptide 2
1
2020
7
0.170
 Why?
Regression Analysis
2
2020
1015
0.170
 Why?
Gastric Inhibitory Polypeptide
1
2020
14
0.170
 Why?
Austria
1
2020
8
0.170
 Why?
Double-Blind Method
1
2025
1978
0.160
 Why?
Skiing
1
2021
51
0.160
 Why?
Energy Intake
1
2023
510
0.160
 Why?
Sensitivity and Specificity
2
2022
1968
0.160
 Why?
Vision Disorders
1
2021
167
0.160
 Why?
Societies, Medical
1
2024
852
0.160
 Why?
Machine Learning
1
2025
554
0.160
 Why?
Glucagon-Secreting Cells
1
2020
23
0.160
 Why?
Psychometrics
2
2021
734
0.160
 Why?
RNA Interference
1
2021
468
0.160
 Why?
Time Factors
4
2026
6944
0.160
 Why?
Injections, Subcutaneous
1
2020
165
0.160
 Why?
Body Weight
1
2024
992
0.150
 Why?
Insulin Antibodies
1
2020
103
0.150
 Why?
Bone Development
1
2019
53
0.150
 Why?
Postprandial Period
1
2020
111
0.150
 Why?
Fatal Outcome
1
2020
307
0.150
 Why?
C-Peptide
1
2020
167
0.150
 Why?
Sodium-Glucose Transporter 2
2
2021
25
0.150
 Why?
Radius
1
2019
51
0.150
 Why?
Healthy Volunteers
1
2019
214
0.150
 Why?
Risk Reduction Behavior
1
2020
226
0.150
 Why?
Infusion Pumps, Implantable
1
2018
26
0.150
 Why?
Patient Acceptance of Health Care
1
2025
876
0.140
 Why?
Cancellous Bone
1
2018
26
0.140
 Why?
Methyldopa
1
2018
7
0.140
 Why?
Social Class
1
2020
268
0.140
 Why?
Benchmarking
1
2019
179
0.140
 Why?
Pelvic Bones
1
2020
129
0.140
 Why?
Postmenopause
1
2020
369
0.140
 Why?
Lumbar Vertebrae
1
2020
248
0.140
 Why?
Sodium Bicarbonate
1
2018
45
0.140
 Why?
Tibia
1
2019
181
0.130
 Why?
HLA-DQ Antigens
1
2018
178
0.130
 Why?
Health Behavior
1
2023
783
0.130
 Why?
Artificial Intelligence
1
2021
332
0.130
 Why?
Coronavirus Infections
1
2022
367
0.130
 Why?
Health Status Disparities
1
2020
297
0.130
 Why?
Child, Preschool
4
2026
11462
0.130
 Why?
Computer-Aided Design
1
2017
41
0.130
 Why?
Uric Acid
1
2018
164
0.130
 Why?
Glucagon
1
2017
104
0.130
 Why?
Antigen Presentation
1
2018
219
0.130
 Why?
Hormones
1
2017
138
0.130
 Why?
Antibody Formation
1
2018
297
0.130
 Why?
Biosensing Techniques
1
2018
138
0.120
 Why?
Immunity, Cellular
1
2018
267
0.120
 Why?
Telemedicine
1
2025
886
0.120
 Why?
Feeding and Eating Disorders
1
2018
168
0.120
 Why?
Alkaline Phosphatase
2
2014
149
0.120
 Why?
Drug Design
1
2017
168
0.120
 Why?
Referral and Consultation
1
2021
794
0.120
 Why?
Health Personnel
1
2022
724
0.120
 Why?
Insulin-Secreting Cells
1
2020
380
0.120
 Why?
Drug Overdose
1
2020
356
0.120
 Why?
Automation
2
2025
100
0.110
 Why?
Circadian Rhythm
1
2019
509
0.110
 Why?
Energy Metabolism
1
2020
930
0.110
 Why?
Parathyroidectomy
1
2014
9
0.110
 Why?
Colesevelam Hydrochloride
1
2013
6
0.100
 Why?
Gastrins
1
2013
8
0.100
 Why?
Allylamine
1
2013
6
0.100
 Why?
Sodium-Glucose Transporter 1
1
2013
11
0.100
 Why?
Insulin Detemir
1
2013
8
0.100
 Why?
Dietary Supplements
1
2018
566
0.100
 Why?
Anemia, Iron-Deficiency
1
2014
60
0.100
 Why?
Insulin, Isophane
1
2013
21
0.100
 Why?
Sulfonylurea Compounds
1
2013
49
0.100
 Why?
Chemistry, Pharmaceutical
1
2013
106
0.100
 Why?
Bionics
2
2023
14
0.100
 Why?
Severity of Illness Index
2
2018
2898
0.100
 Why?
Parathyroid Neoplasms
1
2012
12
0.100
 Why?
Mutation
1
2024
3999
0.100
 Why?
Thiazolidinediones
1
2013
137
0.100
 Why?
Suppuration
1
2012
9
0.100
 Why?
Abdominal Pain
1
2014
144
0.100
 Why?
Recurrence
1
2016
1104
0.100
 Why?
Delayed-Action Preparations
1
2013
175
0.100
 Why?
Hypoparathyroidism
1
2012
7
0.090
 Why?
Diabetic Foot
1
2012
24
0.090
 Why?
Cohort Studies
2
2020
5789
0.090
 Why?
Dogs
1
2013
426
0.090
 Why?
Carotid Intima-Media Thickness
1
2012
68
0.090
 Why?
Leptin
1
2013
238
0.090
 Why?
Hemoglobins
1
2014
361
0.090
 Why?
Soft Tissue Infections
1
2012
41
0.090
 Why?
Cholelithiasis
1
2011
37
0.090
 Why?
Swine
1
2013
809
0.080
 Why?
Biomedical Research
1
2017
680
0.080
 Why?
Adenoma
1
2012
216
0.080
 Why?
Osteomyelitis
1
2012
143
0.080
 Why?
Heart Failure
1
2023
2093
0.080
 Why?
Animals
4
2018
37579
0.080
 Why?
T-Lymphocytes
1
2018
2003
0.080
 Why?
Colorado
1
2019
4597
0.070
 Why?
Staphylococcal Infections
1
2012
391
0.070
 Why?
Pilot Projects
3
2021
1815
0.070
 Why?
Health Knowledge, Attitudes, Practice
1
2015
1395
0.060
 Why?
Recycling
1
2025
8
0.060
 Why?
Citric Acid Cycle
1
2024
58
0.060
 Why?
Disease Progression
2
2026
2791
0.050
 Why?
Natriuretic Peptide, Brain
1
2023
103
0.050
 Why?
Life Style
1
2025
478
0.050
 Why?
Socioeconomic Factors
2
2017
1310
0.050
 Why?
Insulin, Regular, Human
1
2022
48
0.050
 Why?
Needles
1
2022
63
0.050
 Why?
Anti-Bacterial Agents
1
2012
1856
0.040
 Why?
Off-Label Use
1
2021
50
0.040
 Why?
Reference Standards
1
2021
185
0.040
 Why?
Oxidation-Reduction
1
2024
1086
0.040
 Why?
Pancreas
1
2023
326
0.040
 Why?
Sodium
1
2021
195
0.040
 Why?
Monitoring, Ambulatory
1
2020
90
0.040
 Why?
Inpatients
1
2023
512
0.040
 Why?
Microscopy, Polarization
1
2018
31
0.040
 Why?
Hepatitis A Virus Cellular Receptor 1
1
2018
42
0.040
 Why?
Osmolar Concentration
1
2018
167
0.030
 Why?
Multicenter Studies as Topic
1
2019
362
0.030
 Why?
Individuality
1
2019
163
0.030
 Why?
Hospitals
1
2022
694
0.030
 Why?
Skin
1
2022
764
0.030
 Why?
Kidney
1
2024
1475
0.030
 Why?
Hydrogen-Ion Concentration
1
2018
556
0.030
 Why?
Social Determinants of Health
1
2020
273
0.030
 Why?
Prognosis
1
2025
4060
0.030
 Why?
United Kingdom
1
2017
319
0.030
 Why?
Mice, Inbred NOD
1
2018
599
0.030
 Why?
Patient Reported Outcome Measures
1
2020
437
0.030
 Why?
Creatinine
1
2018
490
0.030
 Why?
Insulin Resistance
1
2024
1218
0.030
 Why?
Patient Compliance
1
2020
607
0.030
 Why?
Hospitalization
1
2025
2261
0.030
 Why?
Culture
1
2015
129
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
2056
0.030
 Why?
Erythrocyte Indices
1
2014
30
0.030
 Why?
Glomerular Filtration Rate
1
2018
752
0.030
 Why?
Disease Management
1
2018
628
0.030
 Why?
Cholecalciferol
1
2014
61
0.030
 Why?
Home Care Services
1
2017
260
0.030
 Why?
Emergency Service, Hospital
1
2025
2190
0.030
 Why?
Calcifediol
1
2012
32
0.020
 Why?
Mice, Transgenic
1
2018
2176
0.020
 Why?
Parents
1
2021
1440
0.020
 Why?
Tomography, X-Ray Computed
1
2022
2760
0.020
 Why?
Research Design
1
2017
1104
0.020
 Why?
Drug Resistance, Bacterial
1
2012
189
0.020
 Why?
Microbial Sensitivity Tests
1
2012
366
0.020
 Why?
Tourniquets
1
2011
32
0.020
 Why?
Serum Albumin
1
2011
152
0.020
 Why?
Electronic Health Records
1
2017
1125
0.020
 Why?
Fasting
1
2011
283
0.020
 Why?
Infant
1
2019
9790
0.010
 Why?
Mice
1
2018
18057
0.010
 Why?
Shah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (307) concept(s)
_
Co-Authors Expand Description
See all (44) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)